Sildenafil
Sildenafil
| obere ụdị nke | PDE5 inhibitor  |
|---|---|
| usoro kemịkalụ | C₂₂H₃₀N₆O₄S |
| canonical SMILES | CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C |
| World Health Organisation international non-proprietary name | sildenafil |
| medical condition treated | vasculogenic impotence, pulmonary hypertension, erectile dysfunction |
| na-emekọrịta ihe n'ụzọ anụ ahụ | ATP binding cassette subfamily C member 5, solute carrier organic anion transporter family member 1B3, Solute carrier organic anion transporter family member 2B1, Phosphodiesterase 5A, Phosphodiesterase 6C |
| Ụzọ nke ngafe | oral administration |
| pregnancy category | Australian pregnancy category B1, US pregnancy category B |
| LiverTox likelihood score | LiverTox toxicity likelihood category C |
sildenafil a ọgwụ iji na-emeso akpa ume ọbara mgbali elu na erectile dysfunction.
